Nephrotic Syndrome Latest Advances

Journal: Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia

Published: December 23, 2025

Nephrotic syndrome in mice elevates FGF23 levels and leads to cardiac hypertrophy in the absence of hyperphosphatemia.

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

Published: December 22, 2025

Nephrotic Syndrome Latest Advances

Find the Latest Research About Nephrotic Syndrome

Copy number variation: an important genetic mechanism in SMARCAL1-related immunoosseous dysplasia (Schimke type) in Indian patients.

Copy number variation: an important genetic mechanism in SMARCAL1-related immunoosseous dysplasia (Schimke type) in Indian patients.

Ribbon-like Electron-Dense Deposits in the Subepithelial Layer of Diffuse and Global Glomerular Basement Membrane in Neural Epidermal Growth Factor-like 1-Positive Membranous Nephropathy: A Case Report.

Ribbon-like Electron-Dense Deposits in the Subepithelial Layer of Diffuse and Global Glomerular Basement Membrane in Neural Epidermal Growth Factor-like 1-Positive Membranous Nephropathy: A Case Report.

Hidden Mercury Poisoning Causing Pulmonary Embolism, Nephrotic Syndrome, and Hypothyroidism.

Hidden Mercury Poisoning Causing Pulmonary Embolism, Nephrotic Syndrome, and Hypothyroidism.

Endothelial cell-released CD93 contributes to podocyte injury in idiopathic nephrotic syndrome.

Endothelial cell-released CD93 contributes to podocyte injury in idiopathic nephrotic syndrome.

Lupus podocytopathy: A systematic review of clinical evidence from cases and cohorts.

Lupus podocytopathy: A systematic review of clinical evidence from cases and cohorts.

Biopsy Morphometrics as Predictors of Treatment Response in Primary Nephrotic Syndrome.

Biopsy Morphometrics as Predictors of Treatment Response in Primary Nephrotic Syndrome.

First-line and Second-line Therapy of Zuberitamab in Idiopathic Membranous Nephropathy: A Single-center Retrospective Study.

First-line and Second-line Therapy of Zuberitamab in Idiopathic Membranous Nephropathy: A Single-center Retrospective Study.

Serum Podocalyxin Level as a Potential Biomarker for Diagnosis of Nephrotic Syndrome and Prediction of Steroid Response.

Serum Podocalyxin Level as a Potential Biomarker for Diagnosis of Nephrotic Syndrome and Prediction of Steroid Response.

Obinutuzumab versus Rituximab to maintain remission in children with steroid-dependent and frequently relapsing nephrotic syndrome: the OBIRINS study protocol, a double-blind randomised controlled trial.

Obinutuzumab versus Rituximab to maintain remission in children with steroid-dependent and frequently relapsing nephrotic syndrome: the OBIRINS study protocol, a double-blind randomised controlled trial.

Neuraminidase activity in pediatric nephrotic syndrome.

Neuraminidase activity in pediatric nephrotic syndrome.

Anti-PLA2R Antibody-Positive Membranous Nephropathy Superimposed by Pleural Tuberculosis a Year Later: Mere Association or Actual Cause?

Anti-PLA2R Antibody-Positive Membranous Nephropathy Superimposed by Pleural Tuberculosis a Year Later: Mere Association or Actual Cause?

Nephrotic syndrome in mice elevates FGF23 levels and leads to cardiac hypertrophy in the absence of hyperphosphatemia.

Nephrotic syndrome in mice elevates FGF23 levels and leads to cardiac hypertrophy in the absence of hyperphosphatemia.